Palivizumab ( 帕利珠單抗 )-抗體-抗體-生物在線

女人与狗锁死了视频大全|霍金死亡过程恐怖视频|无节社团简谱季免费观看|六间房直播大厅|中文字幕欧美另类精品|久久人人玩人妻潮喷内射人人|亚洲国产一区二区三区在线观看

福因德科技(武漢)有限公司
Palivizumab ( 帕利珠單抗 )

Palivizumab ( 帕利珠單抗 )

商家詢價

產(chǎn)品名稱: Palivizumab ( 帕利珠單抗 )

英文名稱:

產(chǎn)品編號: FrdE00017

產(chǎn)品價格: null

產(chǎn)品產(chǎn)地: 中國

品牌商標(biāo): Frdbio

更新時間: 2023-08-15T17:03:56

使用范圍: 僅供科研使用

福因德科技(武漢)有限公司
  • 聯(lián)系人 : 趙經(jīng)理
  • 地址 : 光谷國際B座1513
  • 郵編 :
  • 所在區(qū)域 : 湖北省
  • 電話 : 158****4543 點(diǎn)擊查看
  • 傳真 : 點(diǎn)擊查看
  • 郵箱 : 2633787800@qq.com
  • 二維碼 : 點(diǎn)擊查看

Product name:Palivizumab (?帕利珠單抗?)

Catalog No. :?FrdE00017

MW:147700.00 Da

Description:Humanized monoclonal antibody (IgG1k) produced by recombinant DNA technology,directed to an epitope in the A antigenic site of the F protein of respiratory syncytial virus (RSV).Synagis is a composite of human (95%) and murine (5%) antibody sequences.The human heavy chain sequence was derived from the constant domains of human IgG1 and the variable framework regions of the VH genes Cor (1) and Cess (2).The human lightchain sequence was derived from the constant domain of Ck and the variable framework regions of the VL gene K104 withJk-4. Palivizumab is expressed from a stable murine (mouse) myeloma cell line (NS0).Palivizumab is composed of to heavy chains (50.6 kDa each) and two light chains (27.6 kDa each),contains 1-2% carbohydrate by weight and has a molecular weight of 147.7 kDa +/- 1 kDa (MALDI-TOF).

Alternative names:Palivizumab

Specificity target name;species:RSV[Respiratory syncytial virus]

Form:?Liquid

Receptor identification:IgG1-kappa

Storage:?Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 °C for frequent use. Store at -20 to -80 °C for twelve months from the date of receipt.

Purity:The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Note:?This product is for research use only,not for diagnostic or therapeutic use.